Vimarsana
Biggest News Aggregation in the World

Page 32 - Roche Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Group Today - Breaking & Trending Today

Roche to acquire obesity drugmaker Carmot Therapeutics for up to US$3.1B - Vimarsana News

Roche to acquire obesity drugmaker Carmot Therapeutics for up to US$3.1B

Roche is expanding its obesity drug pipeline with the acquisition of Carmot Therapeutics for up to US$3.1 billion. Per the agreement, Roche will pay US$2.7...

Roche Postdoctoral Fellow (RPF) in DNA Damage Response and Synthetic Lethality job with F. Hoffmann-La Roche AG - Vimarsana News

Roche Postdoctoral Fellow (RPF) in DNA Damage Response and Synthetic Lethality job with F. Hoffmann-La Roche AG

Roche Postdoctoral Fellow (RPF) in DNA Damage Response and Synthetic Lethality job in Basel, Canton of Basel-Stadt (CH) with F. Hoffmann-La Roche AG. Apply Today.

Source: nature.com
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO - Vimarsana News

AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO

AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFOOutstanding scientist and entrepreneur Dr. Madiha ...

Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market is on track to achieve US$ 288 - Vimarsana News

Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market is on track to achieve US$ 288

The global Eosinophilic Granulomatosis With Polyangiitis Treatment Market is currently valued at US$ 173.8 Million in 2023 and is anticipated to expand at a CAGR of 5.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 288.5 Million by 2033.The growing occurrences of churg str...

Roche expands hepatitis diagnostics portfolio to help - Vimarsana News

Roche expands hepatitis diagnostics portfolio to help

Elecsys® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active...